Stephanie Lovell - Nov 22, 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Nov 22, 2022
Transactions value $
-$139,602
Form type
4
Date filed
11/23/2022, 03:30 PM
Previous filing
Jun 16, 2022
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Options Exercise $182K +3.8K $47.82 3.8K Nov 22, 2022 Direct
transaction TMDX Common Stock Sale -$220K -3.8K -100% $57.97 0 Nov 22, 2022 Direct
transaction TMDX Common Stock Options Exercise $28.9K +1.1K $26.26 1.1K Nov 22, 2022 Direct
transaction TMDX Common Stock Sale -$63.8K -1.1K -100% $58.04 0 Nov 22, 2022 Direct
transaction TMDX Common Stock Options Exercise $271K +5.66K $47.82 5.66K Nov 23, 2022 Direct
transaction TMDX Common Stock Sale -$337K -5.66K -100% $59.50 0 Nov 23, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -3.8K -21.11% $0.00 14.2K Nov 22, 2022 Common Stock 3.8K $47.82 Direct F1
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -1.1K -48.89% $0.00 1.15K Nov 22, 2022 Common Stock 1.1K $26.26 Direct F1
transaction TMDX Stock Option (Right to Buy) Options Exercise $0 -5.66K -39.84% $0.00 8.54K Nov 23, 2022 Common Stock 5.66K $47.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.